Taylor and Gercel-Taylor [50] |
2008 |
Serous |
Benign ovarian tumors |
Exosomal serum miRNA |
miR-21, miR-141, miR-200a, miR-200b, mir-200c, miR-203, miR-205, miR-214 |
|
Resnick et al. [48] |
2008 |
Generally epithelial ovarian cancer |
Healthy controls |
Serum miRNA |
miR-21, miR-92, miR-93, miR-126, miR-29a |
miR-155, miR-127, miR-99b |
Kan et al. [51] |
2012 |
Serous (high grade) |
Healthy controls |
Serum miRNA |
miR-200a, miR-200b, miR-200c |
|
Chung et al. [52] |
2013 |
Serous |
Healthy controls |
Serum miRNA |
|
miR-132, miR-26a, Let-7b, mir-145 |
Suryawanshi et al. [46] |
2013 |
Endometrioid/Serous |
Healthy controls/Endometriosis |
Plasma miRNA |
miR-16, miR-21, miR-191, miR-4284 |
|
Ji et al. [53] |
2014 |
Generally epithelial ovarian cancer |
Healthy controls/Benign ovarian tumors |
Serum miRNA |
miR-22, miR-93 |
|
Shapira et al. [54] |
2014 |
Serous |
Healthy controls/Benign ovarian tumors |
Plasma miRNA |
|
miR-106b, miR-126, miR-150, miR-17, miR-20a, and miR-92a |